People
Associate
Bren Moreno is an associate on the FDA & Life Sciences team in King & Spalding's Washington, D.C., office. Bren counsels pharmaceutical, biotechnology, and medical device manufacturers on a variety of regulatory and compliance issues.
After studying Biology and Bioethics at the Ohio State University, Bren attended Saint Louis University School of Law, where she served as president of the Health Law Association and Notes & Comments Managing Editor of the Journal of Health Law & Policy.
J.D., Saint Louis University School of Law, summa cum laude
B.S. Biology, The Ohio State University, summa cum laude
March 27, 2023
With Risk Comes Responsibility: EU Proposes High-Risk AI Regulation Affecting Device Manufacturers
March 7, 2023
FDA Issues Draft Guidance on “External Controls” in Clinical Trials to Support Safety and Efficacy of a Drug
January 23, 2023
2022 Year in Review: FDA Drug and Device Advertising and Promotion Enforcement
March 27, 2023
With Risk Comes Responsibility: EU Proposes High-Risk AI Regulation Affecting Device Manufacturers
March 7, 2023
FDA Issues Draft Guidance on “External Controls” in Clinical Trials to Support Safety and Efficacy of a Drug
January 23, 2023
2022 Year in Review: FDA Drug and Device Advertising and Promotion Enforcement
J.D., Saint Louis University School of Law, summa cum laude
B.S. Biology, The Ohio State University, summa cum laude